BofA raised the firm’s price target on Alignment Healthcare (ALHC) to $18.50 from $15.50 and keeps a Buy rating on the shares after the company had “a markedly stronger quarter than most of its peers.” The results and outlook add “significant confidence,” adds the analyst, who sees a high visibility ramp to competitive industry level margins over the next few years while Alignment takes share.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare price target raised to $21 from $14 at Piper Sandler
- Alignment Healthcare Reports Strong Growth in Earnings Call
- Alignment Healthcare: Strong Buy Rating Driven by Operational Efficiency and Promising Growth Outlook
- Alignment Healthcare price target raised to $18 from $16 at Stifel
- Alignment Healthcare price target raised to $9 from $8 at Barclays
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue